John W. Rooney
John W. Rooney, Ph.D., J.D. -- USPTO-Registered Patent & Trademark Attorney, College Professor
Attorney John W. Rooney, Ph.D. is admitted to the Massachusetts State Bar and the U.S. District Court, District of Massachusetts, and is registered with the U.S. Patent and Trademark Office as a U.S. Patent Attorney. He holds degrees from University of California, Berkeley (B.A., Molecular Biology) and Harvard University (Ph.D., Genetics). Prior to becoming an attorney, Dr. Rooney worked as a drug development scientist for multiple biotech and pharmaceutical companies. While in law school he interned at Fletcher Allen Health Care, Burlington, Vermont, under the Offices of Integrity and Compliance, Risk Management, and General Counsel. His practice now focuses on Patent, Trademark, and Theft of Trade Secrets litigation in Federal Court. He is with Aquilla Patents & Marks, PLLC.
John W. Rooney Bar Admissions:
John W. Rooney as been admitted and licensed to practise law by:
- State of Massachusetts
- United States District Court, District of Massachusetts
- USPTO-Registered Patent Attorney
John W. Rooney Memberships:
John W. Rooney is a member of, or is registered with, the following organizations:
- Member, Massachusetts Bar Association (MBA)
- Member, Boston Patent Law Association (BPLA)
- Member, American Intellectual Property Law Association (AIPLA)
- Member, Patent Information Users Group (PIUG)
- Registered Patent Attorney, United States Patent and Trademark Office (USPTO)
John W. Rooney Continuing Legal Education (CLE) and Symposia:
Boston Patent Law Association (BPLA), 06/19/2012: “BPLA Welcomes BIO2012: Biotech and Pharma IP Forum”
Practising Law Insitute (PLI), 06/13/2012: “Fundamentals of Patent Prosecution 2012: A Boot Camp for Claim Drafting & Amendment Writing (NYC).”
American Intellectual Property Law Association (AIPLA), 05/30/2012: “Examiner Interviews 101 – Strategies on How to Make the Most of Your USPTO Interview and Get Your Patent Issued.”
Boston Patent Law Association (BPLA), 05/09/2012: “Patentability of Diagnostic Methods: The European Perspective Post-Mayo.”
Boston Patent Law Association (BPLA), 03/5/2012: “BPLA Reception for the USPTO’s AIA Roadshow in Boston.”
USPTO, 03/05/2012: “USPTO’s AIA Roadshow in Boston.”
Boston Patent Law Association (BPLA), monthly: “Monthly Meeting of the Biotech Case Law Club.”
John W. Rooney Awards:
Academic Excellence Award, Vermont Law School, 2008
Dean’s List, Vermont Law School, 2008
NIH Arteriosclerosis training grant (T32-HL07343), 2000-2001
Postdoctoral Fellowship Award, Cancer Research Institute, New York, NY, 1996-1999
Traveling Scholar Research Award, Tularik, Inc., South San Francisco, CA, 1994-1995
National Research Service Award, 1992-1995
John W. Rooney Publications:
Postel, E. H., Berberich, S. J., Rooney, J. W., and Kaetzel, D. M. (2000). Human NM23/Nucleoside Diphosphate Kinase regulates gene expression through DNA binding to nuclease-hypersensitive transcriptional elements. J. Bioenergetics and Biomembranes 32(3): 277-284.
Rooney, J. W., Postel, E. H., and Calame, K. L. (1999). Proc. 3rd Intern. Congr. Genet. Biochem. Physiol. Nm23/Nucleoside Diphosphate Kinase. University of Bordeaux2, France, 20-22. September 1999, Absh. P15.
Ho, I.-C., Kim, John H.-I., Rooney, J. W., Spiegelman, B. M., and Glimcher, L. H.(1998). A potential role for the nuclear factor of activated T cells family of transcriptional regulatory proteins in adipogenesis. Proc. Natl. Acad. Sci. USA 95, 15537-15541.
Rooney, J. W., Sun, Y.-L., Glimcher, L. H., and Hoey, T. (1995). Novel NF-AT sites that mediate activation of the IL-2 promoter in response to T cell receptor stimulation. Mol. Cell. Biol. 15, 6299-6310.
Rooney, J. W., Hodge, M. R., and Glimcher, L. H. (1995). The proximal promoter of the IL-4 gene is composed of multiple essential regulatory sites which bind at least two distinct factors. J. Immunol. 154, 6397-6405.
Reimold, A. M., Kara, C. J., Rooney, J. W., and Glimcher, L. H. (1993). Transforming Growth Factor Beta-1 Repression of the HLA-DRalpha gene is mediated by conserved proximal promoter elements. J. Immunol. 151, 4173-4182
Miller, C. L., Feldhaus, A. L., Rooney, J. W., Rhodes, L. D., Sibley, C. H., and Singh, H. (1991). Regulation and a possible stage-specific function of Oct-2 during pre-B-cell differentiation. Mol. Cell. Biol. 11, 4885-4894.
Bomstzyk, K., Rooney, J. W., Twasaki, T., Rachie, N. A., Dower, S. K., and Sibley, C. H. (1991). Evidence that interleukin-1 and phorbol esters activate NF-kappa B by different pathways: role of protein kinase C. Cell Regulation 2, 329-335.
Bomsztyk, K., Toivola, B., Emery, D. W., Rooney, J. W., Dower, S. K., Rachie, N. A., and Sibley, C. H. (1990). Role of cAMP in interleukin-1-induced kappa light chain gene expression in murine B cell line. J. Biol. Chem. 265, 9413-9417.
Emery, D. W., Rooney, J. W., and Sibley, C. H. (1989). A gamma interferon-unresponsive variant of cell line, 70Z/3, IFN-4, can be partially rescued by phorbol myristate acetate. Mol. Cell. Biol. 9, 5231-5233.